(1)
Stein Gold, L.; Lebwohl, M.; Bhatia, N. .; DiRuggiero, D.; Jacobson, A.; Pillai, R. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion. J of Skin 2020, 4, s79.